The new external drug for the treatment of psoriasis based on inhibition of serine proteases

• Päätekijät: Alexander S. Zhukov (Tekijä), Evgeny R. Zharun (Tekijä), Vladislav R. Khairutdinov (Tekijä), Alexey V. Samtsov (Tekijä), Mihail Yu. Krasavin (Tekijä), A. V. Garabagiou (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: State Scientific Center of Dermatovenereology and Cosmetology, 2021-07-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Psoriasis is a chronic inflammatory immune-mediated disease characterized by an increased rate of keratinocyte division. The results of recent studies have made it possible to establish that the cytokines of the IL-36 family occupy a significant place in the initiation and regulation of...